基本信息 产品详情 公司简介 推荐产品
  • 首页
  • 个人中心
  • 委托采购
  • 采购清单
网站主页 化工产品目录 生物化工 抑制剂 泛素化抑制剂(Ubiquitin) DUB 抑制剂 ML323 化合物 ML323
  • 化合物 ML323|T1757|TargetMol

化合物 ML323|T1757|TargetMol

ML-323
1572414-83-5
￥278 1mg 起订
￥619 5mg 起订
￥993 10mg 起订
上海 更新日期：2024-12-12

TargetMol中国（陶术生物）

VIP3年
联系人：邵小姐
手机：4008200310 拨打
邮箱：marketing@tsbiochem.com

产品详情:

中文名称：
化合物 ML323
英文名称：
ML-323
CAS号：
1572414-83-5
品牌：
TargetMol
产地：
美国
保存条件：
Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
纯度规格：
99.96%
产品类别：
抑制剂
货号：
T1757

Product Introduction

Bioactivity

名称ML-323
描述ML323 is a reversible and effective USP1-UAF1 inhibitor in a Ub-Rho assay (IC50: 76 nM) and in orthogonal gel-based assays using K63-linked diubiquitin (di-Ub) (IC50: 174 nM 820 nM)and monoubiquitinated PCNA (Ub-PCNA) (IC50: 820 nM) as substrates, respectively.
细胞实验For the colony-forming assay, cells are seeded at a density of 300–500 cells per well in six-well plates and grown overnight. Cells are then treated with ML323 alone, cisplatin alone or a combination of cisplatin and ML323 (1:1 or 1:4) at the indicated concentrations. Cells treated with an equal volume of DMSO and saline are used as control. After 48 h of treatment, fresh growth medium is added, and cells are incubated for an additional 5-10 d to allow for colony formation. For UV combination treatment, the cells are treated with ML323 at the indicated concentrations or an equal volume of DMSO. After 48 h, the medium is removed, and cells are irradiated at 254 nm at the indicated dosage. Fresh growth medium is added, and the cells are incubated for an additional 5-10 d to allow for colony formation. The cells without UV irradiation but treated with ML323 or an equal volume of DMSO are used as controls and designated as 100%. After the formation of the colonies, cells are fixed with methanol and stained with 0.5% crystal violet. Colonies consisting of >50 cells are scored. The number of colonies is determined from triplicate plates. The dose-response curves are generated using GraphPad Prism and analyzed by using CalcuSyn to calculate the combination index, which is determined for the fraction of cells affected after the addition of fixed ratios of cisplatin and the USP1-UAF1 inhibitor. (Only for Reference)
激酶实验High-throughput screening: For HTS, USP1-UAF1 activity is monitored using ubiquitin-rhodamine 110 as a substrate, where hydrolysis of the amide bond between the C-terminal glycine of ubiquitin and rhodamine results in an increase in fluorescence. The assay is miniaturized to a 4 μL volume in a 1,536-well format and is used to screen approximately 402,701 compounds in quantitative HTS mode, with each compound tested over a range of four to five concentrations. The assay shows robust performance with an average Z'factor of 0.8 throughout the screen.
体内活性在H596细胞和U2OS骨肉瘤细胞中,ML323以两个主要的DNA损伤应答途径(TLS 和 FA)为靶点,增强顺铂的细胞毒性。通过抑制H596细胞中USP1–UAF1活性,ML323抑制PCNA和ANCD2去泛素化。
存储条件Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
溶解度Ethanol : 38.5 mg/mL (100 mM)
DMSO : 38.5 mg/mL (100 mM)
关键字Deubiquitinase | Inhibitor | inhibit | ML-323 | DUBs | ML 323
相关产品P22074 | 6-Thioguanine | Vialinin A | N-Ethylmaleimide | BAY 11-7082 | USP15-IN-1 | GRL0617 | USP30 inhibitor 11 | DUB-IN-1 | USP8-IN-3 | SJB3-019A | Spautin-1
相关库抑制剂库 | 经典已知活性库 | 抗癌化合物库 | 已知活性化合物库 | 细胞周期化合物库 | 抗衰老化合物库 | HIF-1化合物库 | NO PAINS 化合物库 | 泛素化化合物库 | DNA 损伤和修复分子库
ML323|TargetMol

公司简介

TargetMol Chemicals Inc. 总部位于马萨诸塞州波士顿，致力于为全球生化领域科学家的研究提供专业的产品和服务。TargetMol?品牌的客户群分布于40多个国家和地区，已发展成为全球知名的化合物库和小分子化合物研究供应商。 TargetMol?可提供160多种满足不同需求的化合物库，以及多种类型的生化试剂产品，包括12000多种抑制剂、16000多种天然产物和各类多肽、抗体、生命科学试剂盒等，此外，我们还建设有CADD（计算机辅助药物设计）研究中心、药理实验室、药化合成平台三大技术中心，全方位满足客户的定制需求。 凭借我们优质的产品和服务、快速高效的全球供应链和专业的技术支持，我们将有效帮助您缩短研发周期，取得更成功的结果。

成立日期 (12年)
注册资本 566.265100万人民币
员工人数 100-500人
年营业额 ￥ 1亿以上
经营模式 贸易,工厂,试剂,定制,服务
主营行业 天然产物,生化试剂,分子生物学,分子砌块,生物技术服务

化合物 ML323相关厂家报价

  • ML-323;ML 323
  • ML-323;ML 323
  • 四川省维克奇生物科技有限公司 VIP
  • 2024-11-21
  • 询价
  • ML323
  • ML323
  • 南京艾尔莎生物科技有限公司 VIP
  • 2023-04-10
  • 询价
内容声明
official 进入官方账号
拨打电话 立即询价